Phathom Pharmaceuticals, Inc. · NASDAQ:PHAT

BlackRock, Inc. reported a 5.50% stake in Phathom Pharmaceuticals, Inc. (Schedule 13G)

Event Jun 30, 2026 · Filed Jul 29, 2026

BlackRock, Inc. reported a 5.50% stake in Phathom Pharmaceuticals, Inc., 4,378,647 shares, as a passive investor on Jun 30, 2026. Filed Jul 29, 2026 (Schedule 13G).

Stake
5.50%
Shares
4,378,647
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
BlackRock, Inc.5.50%4,378,647

Source

View original at SEC

Related